Neumonia adquirida en la comunidad. Guia practica elaborada por un comite intersociedades

Luna, Carlos M; Calmaggi, Anibal; Caberloto, Oscar; Gentile, Jorge; Valentini, Ricardo; Ciruzzi, Julian; Clara, Liliana; Rizzo, Oscar; Lasdica, Sergio; Blumenfeld, Marcelo; Benchetrit, Guillermo; Famiglietti, Angela; Apezteguia, Carlos; Monteverde, Alfredo.
Medicina [B.Aires] ; 63(4): 319-343, 2003. tab
Artículo en Español | BINACIS | ID: bin-5171

Documentos relacionados

  1. Etiology, Treatments, and Outcomes of Patients With Severe Community-Acquired Pneumonia in a Large U.S. Sample.
  2. Childhood community-acquired pneumonia.
  3. Risk factors and predicting nomogram for the clinical deterioration of non-severe community-acquired pneumonia.
  4. Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital.
  5. Study of factors related to recurrence within 30 days after pneumonia treatment for community-onset pneumonia.
  6. Community-Acquired Pneumonia in Children.
  7. Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia.
  8. Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumonia.
  9. Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study.
  10. Impacts of environmental factors on the aetiological diagnosis and disease severity of community-acquired pneumonia in China: a multicentre, hospital-based, observational study.